Buck Elizabeth Insider Trades

Insider Trading History

Track insider trading activity for Buck Elizabeth. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
CHIEF SCIENTIFIC OFFICER
Holding Value $523k 250,000 shares
Last Trade
Jan 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$643k 250,000 shares
$2.57
$2.09
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
CHIEF SCIENTIFIC OFFICER
Holding Value $366k 175,000 shares
Last Trade
Jan 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$441k 175,000 shares
$2.52
$2.09
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
CHIEF SCIENTIFIC OFFICER
Holding Value $418k 200,000 shares
Last Trade
Feb 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$972k 200,000 shares
$4.86
$2.09
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
CHIEF SCIENTIFIC OFFICER
Holding Value $418k 200,000 shares
Last Trade
Feb 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$584k 200,000 shares
$2.92
$2.09
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
CHIEF SCIENTIFIC OFFICER
Holding Value $188k 90,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$341k 90,000 shares
$3.79
$2.09
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Chief Scientific Officer
Holding Value $199k 95,192 shares
Last Trade
Sep 15, 2021 Sale
$1.95M 201,806 shares
$9.64
$2.09

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up